Company profile
Optimi Health Corp.
NASDAQ: OPTH · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Princeton, BCCIK 0002027329Reports USD
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 24
v0.1 · 5/100 weight · pillars only
↑ Altman-Z, market scale · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
$124.7k
Rev growth YoY (TTM)
-68.3%
Net income (FY)
—
Employees
6
as of 2026-08-21
Market cap
$15.7M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Optimi Health Corp.’s financial profile?
Optimi Health Corp. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Cellectar Biosciences, Inc.——ProMIS Neurosciences, Inc.——ImpediMed Limited——Akari Therapeutics, Plc——CS Diagnostics Corp.——BioVie Inc.——Key facts
CEODane Stevens
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersPrinceton, BC
ExchangeNASDAQ: OPTH
Employees6
IPO date2026-05-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.